2779. Efficacy of the Adjuvanted Recombinant Zoster Vaccine According to Sex, Geographic Region, and Geographic Ancestry/Ethnicity: A Post-hoc Analysis

BACKGROUND: The risk of herpes zoster (HZ) has been reported to vary by sex and ethnicity. In 2 large-scale clinical trials, ZOE-50 (NCT01165177) and ZOE-70 (NCT01165229), the adjuvanted recombinant zoster vaccine (RZV) demonstrated high vaccine efficacy (VE) against HZ and post-herpetic neuralgia (...

Descripción completa

Detalles Bibliográficos
Autores principales: Willer, David O, Wascotte, Valentine, Kim, Joon Hyung, Zahaf, Toufik, Talarico, Carla, Gorfinkel, Iris, Gervais, Pierre, Pharm, Pharm, L, Cunningham, Anthony L, Oostvogels, Lidia, Colindres, Romulo, Schuind, Anne
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2019
Materias:
Abstracts
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6810060/
http://dx.doi.org/10.1093/ofid/ofz360.2456

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6810060/
http://dx.doi.org/10.1093/ofid/ofz360.2456

Ejemplares similares